바이오헤이븐 주식회사
US ˙ NYSE ˙ VGG1110E1079

SecurityBHVN / Biohaven Ltd.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership17,975 shares
Latest Disclosed Value $ 152,069
Prudential Financial Inc ownership in BHVN / Biohaven Ltd.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 17,975 shares of Biohaven Ltd. (US:BHVN) valued at $152,069 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of Biohaven Ltd.. The current value of the position is $194,130 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F BIOHAVEN COM G1110E107 17,975 17,975 152 0.0001
2025-11-13 2025-09-30 13F BIOHAVEN COM G1110E107 0 -5,915 -100.00 0 -100.00
2025-08-12 2025-06-30 13F BIOHAVEN COM G1110E107 5,915 190 3.32 263 3.15 0.0003
2025-05-13 2025-03-31 13F BIOHAVEN COM G1110E107 5,725 -255 -4.26 254 -4.15 0.0004
2025-02-11 2024-12-31 13F BIOHAVEN COM G1110E107 5,980 514 9.40 265 -2.93 0.0004
2024-11-14 2024-09-30 13F BIOHAVEN COM G1110E107 5,466 5,466 273 0.0004
2024-08-13 2024-06-30 13F BIOHAVEN COM G1110E107 0 -4,937 -100.00 0 -100.00
2024-05-14 2024-03-31 13F BIOHAVEN COM G1110E107 4,937 252 5.38 270 35.00 0.0004
2024-02-13 2023-12-31 13F BIOHAVEN COM G1110E107 4,685 4,685 201 0.0003
2023-02-14 2022-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 0 -4,511 -100.00 0 -100.00
2022-11-04 2022-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 4,511 -895 -16.56 684 -13.20 0.0012
2022-08-15 2022-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 5,406 -174 -3.12 788 19.03 0.0013
2022-05-13 2022-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 5,580 1,122 25.17 662 0.30 0.0009
2022-02-14 2021-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 4,458 -13,353 -74.97 660 -73.29 0.0008
2021-11-15 2021-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 17,811 13,315 296.15 2,471 465.45 0.0034
2021-08-16 2021-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 4,496 350 8.44 437 54.42 0.0006
2021-05-12 2021-03-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 4,146 77 1.89 283 -18.91 0.0004
2021-08-16 2020-12-31 13F/A-1 BIOHAVEN PHARMACTL HLDG CO L COM 0085 G11196105 4,069 3,171 353.12 349 501.72 0.0006
2021-02-16 2020-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 4,069 3,171 349 0.0006
2021-08-05 2020-09-30 13F/A-1 BIOHAVEN PHARMACTL HLDG CO L COM G11196105 898 749 502.68 58 427.27 0.0084
2020-11-16 2020-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 3,115 2,966 203 0.0004
2021-08-05 2020-06-30 13F/A-1 BIOHAVEN PHARMACTL HLDG CO L COM 0073 G11196105 149 149 11 0.0020
2020-08-12 2020-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 2,985 2,985 218 0.0004
2020-02-11 2019-12-31 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 0 -448 -100.00 0 -100.00
2021-08-05 2019-09-30 13F/A-1 BIOHAVEN PHARMACTL HLDG CO L COM 0041 G11196105 448 -119 -20.99 19 -24.00 0.0062
2019-11-13 2019-09-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 23,740 23,173 990 0.0016
2021-08-05 2019-06-30 13F/A-1 BIOHAVEN PHARMACTL HLDG CO L COM G11196105 567 567 25 0.0087
2019-08-08 2019-06-30 13F BIOHAVEN PHARMACTL HLDG CO L COM G11196105 82,650 3,620 0.0056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.